RT 2 Study

Study Type

General Health & Wellbeing

Study Purpose

The purpose of this study is to examine the safety and tolerability of single doses of the soy-protein Russian Tarragon complex (Russian Tarragon Nutrasorb) versus placebo.

About the Study

The Russian Tarragon comes from a plant source called Artemisia drancunculus. This plant has a long history of health and food use, and has been reported as an effective treatment for diabetes in various parts of the world. For this study, we will also be looking at how effectively the supplement improves carbohydrate metabolism.

Study Design

Number of visits:

  • 1 Screening visit
  • 3 clinic visits
  • 3 overnight visits

Study procedures:

  • Height, weight, vitals
  • ECG
  • Blood draws
  • Oral Glucose Tolerance Test (OGTT)

After completing a screening visit, eligible participants will receive three doses (two doses of the supplement and one dose of placebo) over 3 testing periods, which are each separated by a washout period of at least 7 days. Each testing period involves 3 clinic/inpatient visits. Therefore, if enrolled in the study, you will complete a total of 9 clinic/inpatient visits over approximately four weeks after you complete the screening visit. All study procedures will be provided at no cost to participants.

Study Qualifications

Study Duration

After screening visit approximately 4 weeks


Earn up to $450 for participation.

Study Contact

If you are interested in volunteering for the RT 2 study, click here to screen online, call 225-763-3000 or email clinicaltrials@pbrc.edu.

If you think you may be eligible, please click the button below to screen online.


Please do not fill out this questionnaire for anyone other than yourself unless you are their legal guardian.
If you know someone who may be interested please direct them to the site or have them call us directly at 225-763-3000.


English Calculation
Enter Your Weight: 
Enter Your Height: 
 ft.  in.
Your BMI: